| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. M Clarke, R Collins, S Darby, C Davies, P Elphinstone, E Evans, ... Lancet 366 (9503), 2087, 2005 | 6366 | 2005 |
| Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger … D Grimwade, RK Hills, AV Moorman, H Walker, S Chatters, AH Goldstone, ... Blood, The Journal of the American Society of Hematology 116 (3), 354-365, 2010 | 2259 | 2010 |
| Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Quasar Collaborative Group The Lancet 370 (9604), 2020-2029, 2007 | 1716 | 2007 |
| Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial AD2000 Collaborative Group The Lancet 363 (9427), 2105-2115, 2004 | 1215 | 2004 |
| Association between premature mortality and hypopituitarism JW Tomlinson, N Holden, RK Hills, K Wheatley, RN Clayton, AS Bates, ... The Lancet 357 (9254), 425-431, 2001 | 1202 | 2001 |
| Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ... Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018 | 1141 | 2018 |
| Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials Colorectal Cancer Collaborative Group The Lancet 358 (9290), 1291-1304, 2001 | 1132 | 2001 |
| The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute … RE Gale, C Green, C Allen, AJ Mead, AK Burnett, RK Hills, DC Linch Blood, The Journal of the American Society of Hematology 111 (5), 2776-2784, 2008 | 980 | 2008 |
| Donepezil and memantine for moderate-to-severe Alzheimer's disease R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ... New England Journal of Medicine 366 (10), 893-903, 2012 | 970 | 2012 |
| Assessment of minimal residual disease in standard-risk AML A Ivey, RK Hills, MA Simpson, JV Jovanovic, A Gilkes, A Grech, Y Patel, ... New England Journal of Medicine 374 (5), 422-433, 2016 | 935 | 2016 |
| Factors predisposing women to chronic pelvic pain: systematic review P Latthe, L Mignini, R Gray, R Hills, K Khan Bmj 332 (7544), 749-755, 2006 | 908 | 2006 |
| Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised … RK Hills, S Castaigne, FR Appelbaum, J Delaunay, S Petersdorf, M Othus, ... The lancet oncology 15 (9), 986-996, 2014 | 798 | 2014 |
| A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not … AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, RK Hills, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 766 | 2007 |
| Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial AK Burnett, RK Hills, D Milligan, L Kjeldsen, J Kell, NH Russell, JAL Yin, ... Journal of clinical oncology 29 (4), 369-377, 2011 | 763 | 2011 |
| Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial AK Burnett, NH Russell, RK Hills, D Bowen, J Kell, S Knapper, YG Morgan, ... The lancet oncology 16 (13), 1295-1305, 2015 | 562 | 2015 |
| Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute … D Cilloni, A Renneville, F Hermitte, RK Hills, S Daly, JV Jovanovic, ... Journal of Clinical Oncology 27 (31), 5195-5201, 2009 | 552 | 2009 |
| Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 … JAL Yin, MA O'Brien, RK Hills, SB Daly, K Wheatley, AK Burnett Blood, The Journal of the American Society of Hematology 120 (14), 2826-2835, 2012 | 498 | 2012 |
| Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial AK Burnett, NH Russell, RK Hills, AE Hunter, L Kjeldsen, J Yin, ... Journal of clinical oncology 31 (27), 3360-3368, 2013 | 484 | 2013 |
| Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia AK Burnett, NH Russell, RK Hills, J Kell, S Freeman, L Kjeldsen, ... Journal of clinical oncology 30 (32), 3924-3931, 2012 | 466 | 2012 |
| Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine … Stem Cell Trialists’ Collaborative Group Journal of clinical oncology: official journal of the American Society of …, 2005 | 464 | 2005 |
